10x genomics stock price.

Nov 24, 2023 · Based on short-term price targets offered by 12 analysts, the average price target for 10x Genomics comes to $56.00. The forecasts range from a low of $30.00 to a high of $70.00. The average price ...

10x genomics stock price. Things To Know About 10x genomics stock price.

10x Genomics appears to be significantly undervalued based on the GF Value calculation. At its current price of $47.68 per share, the stock's long-term return is likely to be much higher than its ...10x Genomics was founded in 2012 by Serge Saxonov, Ben Hindson and Kevin Ness to create advanced testing equipment for use in cellular biology. [3] Prior to starting the company, Saxonov was the founding architect, and director of research and development at 23andMe. [2] Ness left 10x Genomics in December 2016 [4] and in 2018, Justin …Jul 27, 2022 · 10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. ... Consensus Price Target is the stock price analysts ... Get 10x Genomics, Inc. (TXG) real-time share value, investment, rating and financial market information from Capital. ... To be able to trade stocks like this, create an account and apply for a stock listing. Create Account. Market Trading Hours* ... T. Rowe Price Associates, Inc. Investment Advisor: 2.5186: 2603267: 244613: 2023-06-30: LOW ...

Summary of all time highs, changes and price drops for 10x Genomics; Historical stock prices; Current Share Price: US$43.36: 52 Week High: US$63.57: 52 Week LowTXG 10x Genomics Inc - Class A Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NASDAQ)As you may know, genomics stocks have been red hot over the past couple years. For example, Intellia (NTLA) and 10x Genomics (TXG) have surged 550% and 277% since 2019. MORE FOR YOU

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. ... Consensus Price Target is the stock price analysts ...

PLEASANTON, Calif., April 12, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced it will report financial results for the first quarter 2023 after market close on Wednesday, May 3, 2023.The company will host a conference call and live …Why 10x Genomics Stock Is Sinking Today. ... Price as of December 1, 2023, 3:18 p.m. ET ... Shares of 10x Genomics (TXG 3.98%) have sunk 13.9% as of 10:56 a.m. ET on Thursday. The big decline came ...Get the latest 10X Genomics (TXG) stock forecast for tomorrow and next week. Stay ahead of the game with our 10X Genomics stock price prediction for 2025 ...Jul 6, 2023 · At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

10x Genomics share price went up by 15.79% last month. The next quarterly earnings date for 10x Genomics is scheduled on February 15, 2024. 10x Genomics's next ex-dividend date is May 26, 2020.

Serge Saxonov 10x Genomics (TXG) Stock Price Performance 10x Genomics (TXG) Stock Key Data Summary Additional Data Analysts Historical Quotes …

Use our historic performance chart to see real-time 10x Genomics Inc Class A stock price and the 10x Genomics Inc Class A news feed to help further your research before investing in fractional shares with any dollar amount you choose. 2. Choose a Stash plan and set up your investment account in just a few minutes.Baron Discovery Fund (the Fund) reached its 10-year anniversary on September 30, 2023. Since inception, on a cumulative basis, the fund was up 195.3% (Institutional Shares) compared to the Russell 2000 […] Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and ...UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating. Nov. 07. MT. OWKIN Integrates 10x Genomics, Inc. Spatial Omics and Single-Cell Technologies to the MOSAIC Study. Nov. 06. CI. Earnings Flash (TXG) 10X GENOMICS Reports Q3 Revenue $153.6M, vs. Street Est of $151.3M. Nov. 02.Nov 23, 2023 · CI. UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating. Nov. 07. MT. OWKIN Integrates 10x Genomics, Inc. Spatial Omics and Single-Cell Technologies to the MOSAIC Study. Nov. 06. CI. Earnings Flash (TXG) 10X GENOMICS Reports Q3 Revenue $153.6M, vs. Street Est of $151.3M. Nov. 02.

10x Genomics grew its revenue by 75% over the last year. That's a strong result which is better than most other loss making companies. Given the revenue growth, the share price drop of 18% seems ...10x Genomics ( TXG) - Get Free Report jumped 20% from a closing price of $44.94 a share on Aug. 9 to a high of $53.76 on Aug. 11. It closed at $30.76 on Sept. 2. That's a 22% decline from the pre ...Get a real-time 10x Genomics, Inc. (TXG) stock price quote with breaking news, financials, statistics, charts and more.PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent ...10x Genomics was founded in 2012 by Serge Saxonov, Ben Hindson and Kevin Ness to create advanced testing equipment for use in cellular biology. [3] Prior to starting the company, Saxonov was the founding architect, and director of research and development at 23andMe. [2] Ness left 10x Genomics in December 2016 [4] and in 2018, Justin …If you are thinking of buying or selling 10x Genomics stock, ... The 52-week range of Verizon's stock price was $30.135 to $44.73. Verizon's dividend yield is 7.24%. It paid $8.2 billion in ...

10x Genomics Inc Ordinary Shares - Class A TXG Morningstar Rating Unlock Stock XNAS Rating as of Dec 1, 2023 Summary Chart News Price vs Fair Value …

With 10x Genomics stock trading at $38.51 per share, the total value of 10x Genomics stock (market capitalization) is $4.52B. 10x Genomics stock was originally listed at a price of $52.75 in Sep 12, 2019.Whole genome sequencing can analyze a baby's DNA and search for mutations that may cause health issues now or later in life. But how prepared are we for this knowledge and should it be used on all babies? Advertisement For most of human his...As of Dec. 31, 10x had $219.7 million in cash and cash equivalents, $210.2 million in marketable securities, and $2.6 million in restricted cash. 10x Genomics expects full-year 2023 revenue to be in the range of $580 million to $600 million, representing 12 percent to 16 percent growth over 2022 revenue.The latest closing stock price for 10x Genomics as of November 03, 2023 is 39.72. The all-time high 10x Genomics stock closing price was 202.37 on April 26, 2021. The 10x Genomics 52-week high stock price is 63.57, which is 60% above the current share price. The 10x Genomics 52-week low stock price is 30.19, which is 24% below the current share ...Buy 10X Genomics Stock. 10X Genomics is a health information services business based in the US. 10X Genomics shares (TXG.US) are listed on the NASDAQ and all prices are listed in US dollars. Its last market close was $45.75 – an increase of 5.12% over the previous day. 10X Genomics employs 1,243 staff and has a trailing 12-month revenue of ...8 analysts have issued 12 month target prices for 10x Genomics' stock. Their TXG share price targets range from $47.00 to $75.00. On average, they predict the company's stock price to reach $60.78 in the next twelve months. This suggests a possible upside of 42.3% from the stock's current price.View the latest 10x Genomics Inc. (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ.Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap.

Nov 27, 2023 · Get a real-time 10x Genomics, Inc. (TXG) stock price quote with breaking news, financials, statistics, charts and more.

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...

Future criteria checks 4/6. 10x Genomics is forecast to grow earnings and revenue by 57.1% and 14% per annum respectively. EPS is expected to grow by 57.5% per annum. Return on equity is forecast to be -13.2% in 3 years.Information on stock, financials, earnings, subsidiaries, investors, and executives for 10x Genomics. Use the PitchBook Platform to explore the full profile.Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing. For instruments denominated in GBX, the Trade Value is in GBP when the traded currency is GBX or GBP. When the traded price is any other currency then the ...Nov 13, 2023 · OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study November 6, 2023. 10x Genomics Reports Third Quarter 2023 Financial Results November 2, 2023. 10x Genomics to Present at the Stephens 25th Annual Conference November 1, 2023. Study Fueled by Xenium Analysis Sheds Light on Resistance Mechanisms in Model ... Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing.10x Genomics Inc experienced a daily loss of 5.62% and a 3-month loss of 12.81%.The company also reported a Loss Per Share of 1.49. Despite these figures, we aim to explore whether the stock is ...Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important ...

Nov 17, 2023 · Investor Relations. We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across diverse ... Serge Saxonov 10x Genomics (TXG) Stock Price Performance 10x Genomics (TXG) Stock Key Data Summary Additional Data Analysts Historical Quotes …Source: Kantar Media. View the latest 10x Genomics Inc. (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ.Nov 7, 2023 · Future criteria checks 4/6. 10x Genomics is forecast to grow earnings and revenue by 57.1% and 14% per annum respectively. EPS is expected to grow by 57.5% per annum. Return on equity is forecast to be -13.2% in 3 years. Instagram:https://instagram. eqt corporation stocksound hound stock pricedeere and company stockwho owns weight watchers As of Dec. 31, 10x had $219.7 million in cash and cash equivalents, $210.2 million in marketable securities, and $2.6 million in restricted cash. 10x Genomics expects full-year 2023 revenue to be in the range of $580 million to $600 million, representing 12 percent to 16 percent growth over 2022 revenue. platinum etfsstock aristocrats 10x Genomics stock opened at $34.93 on Monday. The firm's market capitalization is $4 billion, its price-to-earnings ratio is -23.60, and its beta is 1.70.Read Full Company Summary for TXG here. View 10x Genomics TXG investment & stock information. Get the latest 10x Genomics TXG detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. you tube storyline online PLEASANTON, Calif., April 12, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced it will report financial results for the first quarter 2023 after market close on Wednesday, May 3, 2023.The company will host a conference call and live …8 analysts have issued 12 month target prices for 10x Genomics' stock. Their TXG share price targets range from $47.00 to $75.00. On average, they predict the company's stock price to reach $60.78 in the next twelve months. This suggests a possible upside of 42.3% from the stock's current price.Sure, at a price-to-sales ratio of 35, the stock looks expensive. But you get to own a dominant company that has plenty of runway to go. 10x Genomics has created its own market and is actively ...